- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
ProPhase Labs Inc (PRPH)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/09/2025: PRPH (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $13.8
1 Year Target Price $13.8
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -64.12% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.88M USD | Price to earnings Ratio - | 1Y Target Price 13.8 |
Price to earnings Ratio - | 1Y Target Price 13.8 | ||
Volume (30-day avg) 1 | Beta -0.64 | 52 Weeks Range 0.12 - 0.93 | Updated Date 12/9/2025 |
52 Weeks Range 0.12 - 0.93 | Updated Date 12/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.98 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -539.52% |
Management Effectiveness
Return on Assets (TTM) -23.5% | Return on Equity (TTM) -220.34% |
Valuation
Trailing PE - | Forward PE 10.09 | Enterprise Value 13651704 | Price to Sales(TTM) 1.36 |
Enterprise Value 13651704 | Price to Sales(TTM) 1.36 | ||
Enterprise Value to Revenue 2.7 | Enterprise Value to EBITDA 2.45 | Shares Outstanding 46179017 | Shares Floating 42845816 |
Shares Outstanding 46179017 | Shares Floating 42845816 | ||
Percent Insiders 7.55 | Percent Institutions 6.89 |
Upturn AI SWOT
ProPhase Labs Inc

Company Overview
History and Background
ProPhase Labs Inc. (formerly CMG International, Inc.) underwent a significant transformation. Originally a company involved in the distribution of medical devices and supplies, it pivoted to focus on the consumer health and wellness market. A key milestone was the rebranding and repositioning as ProPhase Labs Inc., signaling a strategic shift towards developing and marketing a range of dietary supplements and over-the-counter (OTC) health products.
Core Business Areas
- Consumer Health & Wellness Products: ProPhase Labs Inc. develops, manufactures, and markets a portfolio of dietary supplements and OTC health products. These products are designed to address various consumer health needs, including immune support, energy, and general wellness. The company focuses on leveraging science-backed ingredients and formulations to create products that appeal to a health-conscious consumer base.
- E-commerce and Direct-to-Consumer (DTC) Sales: A significant portion of ProPhase Labs' strategy involves direct sales through its own e-commerce platforms and potentially third-party online retailers. This allows the company to build direct relationships with consumers, control brand messaging, and capture higher margins compared to traditional retail distribution.
Leadership and Structure
ProPhase Labs Inc. is led by a management team responsible for its strategic direction, product development, marketing, and operations. The organizational structure is typical for a consumer health company, with departments for research and development, sales and marketing, operations, finance, and administration.
Top Products and Market Share
Key Offerings
- Product Name 1: ProPhase Immune Support Products: These are a range of supplements designed to bolster the immune system. They often contain vitamins, minerals, and herbal extracts. While specific market share data for individual ProPhase products is not publicly disclosed, the broader immune support supplement market is highly competitive. Key competitors in this space include large supplement brands like NOW Foods, Garden of Life, Nature's Way, and various private label brands offered by major retailers. Revenue from specific products is not itemized in public filings. The market share for any single product from ProPhase is likely very small due to intense competition from established players.
- Product Name 2: ProPhase Energy & Wellness Supplements: This category includes products aimed at boosting energy levels and promoting overall well-being. Ingredients may include B vitamins, adaptogens, and other performance-enhancing compounds. Similar to immune support products, specific market share and revenue data are not available. The competitors are numerous, ranging from global nutritional giants to niche supplement manufacturers. The market share for these products within their respective categories is likely modest.
Market Dynamics
Industry Overview
ProPhase Labs operates within the rapidly growing global dietary supplement and consumer health market. This industry is characterized by increasing consumer awareness of health and wellness, demand for natural and organic products, and a strong emphasis on preventative health measures. The market is fragmented, with a mix of large multinational corporations, specialized brands, and a significant number of smaller players.
Positioning
ProPhase Labs positions itself as a provider of science-backed, high-quality consumer health products, with a strategic focus on direct-to-consumer sales channels. Its competitive advantage lies in its agility to adapt to market trends, its ability to develop specialized formulations, and its direct engagement with consumers through online platforms.
Total Addressable Market (TAM)
The global dietary supplement market is estimated to be worth billions of dollars and is projected to continue growing. For instance, various market research reports project the global dietary supplement market to reach over $300 billion by 2027. ProPhase Labs, as a relatively smaller player, aims to capture a niche within this vast market by focusing on specific product categories and leveraging its DTC strategy. Its current position is that of a participant aiming to gain market share within specific segments of this large TAM.
Upturn SWOT Analysis
Strengths
- Focus on growing consumer health and wellness market
- Direct-to-consumer (DTC) sales model can offer higher margins and direct customer relationships
- Agility to adapt to emerging health trends and product development
- Potential for product innovation in niche areas
Weaknesses
- Relatively small brand recognition compared to established players
- Dependence on a limited number of product lines
- Challenges in achieving significant scale and market share against larger competitors
- Potential for higher customer acquisition costs in DTC marketing
Opportunities
- Expansion into new product categories and health concerns
- Leveraging e-commerce growth and digital marketing strategies
- Strategic partnerships or acquisitions to expand product portfolio or market reach
- Increasing consumer demand for personalized nutrition and wellness solutions
- International market expansion
Threats
- Intense competition from a large number of established and emerging brands
- Regulatory changes affecting the dietary supplement industry
- Supply chain disruptions and volatility in raw material costs
- Negative publicity or product recalls impacting brand reputation
- Economic downturns affecting consumer discretionary spending on health products
Competitors and Market Share
Key Competitors
- NOW Foods (Private)
- Garden of Life (Part of Nestle Health Science)
- Nature's Way (Part of Schwabe North America)
- GNC Holdings, LLC (Private)
- Nutrabolt (Private)
- NBTY (The Bountiful Company - Part of Nestle Health Science)
Competitive Landscape
ProPhase Labs faces a highly competitive landscape dominated by larger, well-established companies with extensive distribution networks and significant marketing budgets. ProPhase's advantages lie in its targeted approach to niche markets and its direct-to-consumer strategy, which can foster stronger brand loyalty and potentially higher margins. However, its smaller scale makes it susceptible to pricing pressures and the marketing reach of larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historically, ProPhase Labs has experienced periods of revenue fluctuation as it navigated its transition into the consumer health market. The focus has been on building its brand, expanding its product offerings, and developing its DTC sales channels. Growth has likely been driven by new product launches and increased marketing efforts.
Future Projections: Future projections would typically come from analyst reports, if available, or from management's own guidance. These projections would consider market trends, planned product development, marketing strategies, and anticipated sales growth through its e-commerce channels. Key growth drivers are expected to be continued product innovation and expansion of its customer base.
Recent Initiatives: Recent initiatives likely include the expansion of its product line, enhancement of its e-commerce platform, increased digital marketing spend to drive DTC sales, and potentially exploring strategic partnerships or collaborations to accelerate growth.
Summary
ProPhase Labs Inc. is positioned within the dynamic consumer health and wellness market, leveraging a direct-to-consumer strategy. Its strengths lie in product innovation and adaptability, while facing challenges from intense competition and brand recognition issues. The company needs to focus on expanding its market share, achieving consistent profitability, and effectively navigating regulatory landscapes to ensure sustainable growth and overcome competitive pressures.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings with the U.S. Securities and Exchange Commission (SEC)
- Financial news and market data providers
- Industry research reports (for market size and trends)
Disclaimers:
This analysis is based on publicly available information and general market knowledge. It is not intended as investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ProPhase Labs Inc
Exchange NASDAQ | Headquaters Garden City, NY, United States | ||
IPO Launch date 1997-01-16 | Chairman & CEO Mr. Ted William Karkus | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 96 | Website https://www.prophaselabs.com |
Full time employees 96 | Website https://www.prophaselabs.com | ||
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

